Altria-Commissioned Study: 99% of Discarded E-Cigarettes in New York Come from China, Half are Air Bar Products

Market by 2FIRSTS, edited by Sophia Lv
May.31.2024
Altria-Commissioned Study: 99% of Discarded E-Cigarettes in New York Come from China, Half are Air Bar Products
Illegal Chinese-flavored e-cigarette products flood New York, prompting crackdown by authorities to protect children and teens.

According to a study commissioned by the second largest tobacco company in the United States, Altria, reported by YahooFinance on May 30th, nearly every e-cigarette used by people in New York City is illegally imported flavored e-cigarettes from China.

Altria-Commissioned Study: 99% of Discarded E-Cigarettes in New York Come from China, Half are Air Bar Products

 

Market intelligence company WSPM, commissioned by Ochiai, analyzed 100 different locations in various districts of New York City where empty e-cigarette products were discarded.

 

During the period from February 1st to March 21st this year, collectors discovered 2,000 discarded e-cigarette packages. Of these e-cigarettes, 99% were imported from China and 99% were disposable flavored e-cigarettes. New York banned these types of e-cigarettes in 2020 because they are appealing to children and teenagers.

 

David Sutton, spokesperson for Ochiai, stated, "The most popular e-cigarette brands among children have flooded into New York. We strongly support New York's efforts to increase enforcement and remove these illegal products from the market."

 

The spokeswoman for New York Governor Kathy Hochul stated that they "take this issue very seriously," but also noted that data from the state health department shows a decrease in the number of high school students using e-cigarettes from 2018 to 2022.

 

In addition, a spokesperson for New York City Mayor Eric Adams stated that over the weekend, the New York City Sheriff's Office and the New York Police Department "captured a major distributor" who was allegedly selling millions of dollars worth of illegal e-cigarette products.

 

The spokesperson wrote in an email to Fortune magazine: "We are facing a rampant problem of e-cigarette and heated tobacco use among young people, and we will not stand idly by as manufacturers and wholesalers supply our city with illegal harmful products, targeting the most vulnerable New Yorkers - children.

 

The United States Food and Drug Administration (FDA) has only authorized 23 tobacco-flavored e-cigarette products and devices for the market, including NJOY e-cigarette by Altria. However, these FDA-authorized products are not very popular, making up only 2.4% of e-cigarette sales in 2023.

 

Acia appears to have been impacted. Last year, the company sued 34 domestic and foreign e-cigarette manufacturers, demanding compensation for losses caused by "unfair competition," and urging the FDA to enforce its own regulations.

 

An FDA spokesperson declined to answer specific questions regarding enforcement but stated that the agency is taking action across the entire supply chain, including manufacturers, importers, distributors, and retailers. The FDA has issued import alerts to multiple Chinese tobacco companies, such as Shenzhen Heaven Gifts (iMiracle Technology), which produce popular e-cigarette brands ElfBar, EBCreate, and Lost Mary. Import alerts allow FDA field personnel to detain certain products without physical examination.

 

Last December, the FDA announced that they had seized and destroyed e-cigarette flavorings from Heaven Gifts (iMiracle) worth $18 million. However, the company has avoided customs multiple times by changing the name to ElfBar, importing products worth hundreds of millions of dollars.

 

Another illegal Chinese e-cigarette brand, Air Bar, has taken the lead in a study conducted in New York City. Among the e-cigarettes found in large trash bins, 50% were Air Bar products, including flavors such as "pink lemonade" and "blueberry ice."

 

In response, Air Bar's compliance director Quentin Brunel confirmed that the company is headquartered in China but declined to comment on the study.

 

According to reports, the applicant for the 34-tobacco smoking device trademark of Air Bar is Shenzhen Youme Network Technology Co., Ltd., established in 2014 and located in Shenzhen, Guangdong Province. Shenzhen Heaven Gifts Technology Co., Ltd. holds a 14.59% stake in the company.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

South Korea Fully Reviews Nicotine-Analog and Nicotine-Free Vape Liquid Imports, With Over 99% From China and Chinese Supply-Chain Documents Under Scrutiny
South Korea Fully Reviews Nicotine-Analog and Nicotine-Free Vape Liquid Imports, With Over 99% From China and Chinese Supply-Chain Documents Under Scrutiny
Korea Customs Service has tightened import controls on nicotine-analog and nicotine-free e-cigarette liquids, placing the products under 100% document review and subjecting all e-cigarette liquid import declarations to pre-clearance ingredient analysis. As of September 20, 2026, South Korea had imported about 15 metric tons of nicotine-analog liquids, 99.99% from China, and about 316 metric tons of nicotine-free liquids, including roughly 315 metric tons, or 99.7%, from China. The measures follow South Korea's April expansion of its tobacco definition to include synthetic nicotine products and include new checks on Chinese manufacturing, transaction and export documentation.
Sep.24
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Eleftheria (Ria) Kioupritzi, a biopharmaceutical professional with more than 15 years of experience, has joined Philip Morris International as Director Scientific Affairs within Corporate Affairs. She previously served at Roche as Senior Scientific Communications Director for Neuroscience and Rare Diseases and worked extensively in spinal muscular atrophy. Her earlier career also covered competitive intelligence, clinical and regulatory monitoring, pipeline development and launch preparation. During her time working in Roche's SMA field, Evrysdi passed through several U.S. FDA milestones, including its initial approval, an expanded indication for younger infants and approval of a tablet formulation. Public records do not show that Kioupritzi herself led the FDA submissions.
Sep.22
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Nicotine analogues such as 6-methylnicotine are already appearing in e-cigarettes and oral pouches, even as key human evidence remains limited. A new Nixodine-S study adds nonclinical data showing differences from nicotine in cytotoxicity and receptor activity, while independent studies point to a more complex toxicological picture. With supply-chain activity growing and FDA seeking clearer authority over nicotine analogues, the industry now faces a larger question: what evidence is needed before these substances can credibly replace nicotine?
SCIENCE
Sep.23
GAO Audit Finds Nearly 132,000 FDA Tobacco Applications Waiting an Average 1,266 Days as Nicotine Pouch Pilot Practices Move Into Vape PMTA Reviews
GAO Audit Finds Nearly 132,000 FDA Tobacco Applications Waiting an Average 1,266 Days as Nicotine Pouch Pilot Practices Move Into Vape PMTA Reviews
A U.S. Government Accountability Office audit found that 131,915 tobacco product applications submitted to the FDA since 2018 remained without a final review as of December 31, 2025, with pending applications waiting an average of 1,266 days. GAO also found FDA lacks the data needed to systematically determine whether scientific reviews meet applicable timelines. HHS agreed to upgrade the agency's tracking systems. At the same time, FDA has begun applying lessons from its nicotine pouch PMTA pilot to e-cigarette reviews, while changes to enforcement policy and electronic submissions are making the specific stage of a PMTA increasingly relevant to market access.
FDA
Oct.03
Texas Extends Tobacco Tax Interpretation to a 6-Methylnicotine Product, Citing VELO Ruling
Texas Extends Tobacco Tax Interpretation to a 6-Methylnicotine Product, Citing VELO Ruling
The Texas Comptroller of Public Accounts ruled in September 2026 that a combustible product made with non-tobacco plant material and 6-methylnicotine (6-MN), a synthetic nicotine analog, qualifies as a taxable tobacco product. The applicant said the product contained neither tobacco leaf nor measurable conventional nicotine. The determination applies reasoning from a May Texas Supreme Court decision involving VELO nicotine pouches, finding that the plant material and 6-MN together perform the functions of tobacco in a conventional smoking product. The ruling carries applicable tax, licensing and reporting obligations but is limited to the facts submitted by the taxpayer. It does not establish a blanket tax classification for all 6-MN products or extend the same conclusion to e-cigarettes.
Regulations
Nov.06
Wall Street Journal: U.S. FDA Plans Faster Vape and Nicotine Pouch Reviews, Revisit of 2021 PMTA Rule
Wall Street Journal: U.S. FDA Plans Faster Vape and Nicotine Pouch Reviews, Revisit of 2021 PMTA Rule
The Trump administration is preparing changes intended to accelerate FDA market authorization reviews for e-cigarettes and nicotine pouches, according to The Wall Street Journal. The FDA is expected to revisit its 2021 PMTA rule and may simplify some scientific study requirements and shorten review times. The agency has not formally announced the changes. Over the past year, the FDA has already accelerated nicotine-pouch reviews, expanded ENDS authorizations and upgraded its CTP Portal NextGen application system. As of August 2026, 43 nicotine pouch products and 48 e-cigarette products had received FDA marketing authorization.
Sep.24